Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Sensory and Motor Systems

Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain

Ihab Daou, Hélène Beaudry, Ariel R. Ase, Jeffrey S. Wieskopf, Alfredo Ribeiro-da-Silva, Jeffrey S. Mogil and Philippe Séguéla
eNeuro 25 February 2016, 3 (1) ENEURO.0140-15.2016; DOI: https://doi.org/10.1523/ENEURO.0140-15.2016
Ihab Daou
1Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hélène Beaudry
1Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
3Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ariel R. Ase
1Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey S. Wieskopf
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
4Department of Psychology, McGill University, Montreal, Quebec H3A 1B1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfredo Ribeiro-da-Silva
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
3Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey S. Mogil
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
4Department of Psychology, McGill University, Montreal, Quebec H3A 1B1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Séguéla
1Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada
2The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Distribution and functionality of Arch-EGFP pumps in the peripheral sensory pathways of Nav1.8-Arch+ mice. Confocal micrographs showing the fluorescence of Arch-EGFP (green), CGRP immunostaining (blue), P2X3 labeling (red), and the merge. A, Arch-EGFP colocalizes with either P2X3 or CGRP in dorsal root ganglia neurons, validating its selective expression in nociceptors. B, Arch-EGFP fluorescence overlaps with CGRP and P2X3 labeling in laminae I and II of the dorsal horn of spinal cord. C, Arch-EGFP colocalizes with CGRP and P2X3 in free nerve endings in the lower and upper dermis of glabrous skin. Insets are at lower magnification (20×). Scale bars, 50 μm. D, Representative yellow (589 nm) light-induced outward photocurrent and membrane hyperpolarization in a DRG neuron. Magnification shows an inward deflection in the voltage-clamp trace (arrow), illustrating a proton-mediated ASIC-like current. This inward current did not translate into a depolarization in the current-clamp trace. E, Arch-mediated blockade of electrically induced action potentials (10 ms, 0.4 nA current injection) in DRG neurons. Optical stimulation was continuous (intensity, 0.83 mW/mm2). Vh = −60 mV in voltage-clamp configuration; and the resting membrane potential was −62.23 ± 2.92 mV in current-clamp configuration (n = 8–9 cells).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Analgesic effect of acute yellow light stimulation under normal and inflammatory conditions in Nav1.8-Arch+ mice, and under prolonged blue light stimulation in Nav1.8-ChR2+-Arch+ mice. A, Mechanical sensitivity of Nav1.8-Arch+ mice under normal conditions, using different yellow light (589 nm) intensities (n = 8–17 mice/condition; paired Student’s t test, No light vs 0.25 mW/mm2 measurements, p = 0.0707a; Table 1). B, C, Optical stimulation reduced mechanical allodynia under capsaicin- and zymosan- induced inflammation. Yellow light (0.25 mW/mm2) was applied to the hindpaw of Nav1.8-Arch+ mice simultaneously with the mechanical stimulus at each time point postinjection (n = 6–13 mice/condition). D, E, Simultaneous application of yellow and blue light to the hindpaw of Nav1.8-ChR2+-Arch+ mice prevented the development of blue light-induced mechanical (D) and thermal (E) hypersensitivity. Post-treatment measurements were taken without any optical stimulation (n = 6–13 mice/condition). Symbols represent the mean ± SEM of hindpaw withdrawal thresholds and latencies before (Pre) and after (Post) treatment. Data were analyzed using repeated-measures two-way ANOVA followed by Sidak post hoc test. Significance (*) is reported between Ipsi-Light and Ipsi-Control (B, C) and between Ipsi-Blue and Ipsi-Blue + Yellow (D, E). *p < 0.05, **p < 0.01, ****p < 0.0001. F, Representative yellow (589 nm) and blue (473 nm) light-induced photocurrents in DRG neurons from Nav1.8-ChR2+-Arch+ mice. Arch-mediated membrane hyperpolarization was sufficient to block ChR2-induced action potentials (50 ms pulses) in the same neuron (n = 4–5 cells). Light intensity was 0.78 mW/mm2 (blue) and 0.83 mW/mm2 (yellow).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Analgesic effect of prolonged yellow light stimulation under inflammatory conditions in Nav1.8-Arch+ mice. Orange bars represent the hour-long yellow light stimulations. A, Prolonged silencing of Nav1.8+ fibers led to poststimulation analgesia, reducing zymosan-mediated mechanical allodynia. Optical stimulation was performed right after, 2 h after, and 4 h after zymosan injection (n = 7–11 mice/condition). B, Prolonged yellow light stimulation reduced CFA-induced thermal hypersensitivity when applied 24 h after CFA injection but not right after (n = 5–7 mice/condition). C, Hour-long stimulation does not affect thermal sensitivity in naive Nav1.8-Arch+ mice (n = 6 mice). D, Representative traces showing consistent and reproducible Arch-mediated hyperpolarizations in cultured DRG neurons at 1 and 10 min during a sustained 3 s ON, 1 s OFF stimulation protocol (n = 3 cells). Symbols represent the mean ± SEM of hindpaw withdrawal thresholds and latencies before (Pre) and after (Post) treatment. Significance between Ipsi-Light and Ipsi-Control measured using repeated-measures two-way ANOVA followed by Sidak post hoc test: *p < 0.05, ***p < 0.001, ****p < 0.0001.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Analgesic effect of prolonged optical stimulation under neuropathic conditions in Nav1.8-Arch+ mice. Orange bars represent the hour-long optical stimulations. Prolonged yellow light application on the neuropathic hindpaw decreased SNI-induced mechanical allodynia, showing partial analgesia lasting up to 24 h poststimulation, at 3, 4, and 6 weeks after SNI surgery (n = 7–14 mice for SNI; n = 3–7 mice for sham). Symbols represent the mean ± SEM of hindpaw withdrawal thresholds before (Pre) and after (Post) treatment. Significance between SNI-Light and SNI-Iso, measured using repeated-measures two-way ANOVA followed by Sidak post hoc test: *p < 0.05. Significance between each Post time point and Pre in the SNI-Light group, measured using repeated-measures one-way ANOVA followed by Dunnett’s post hoc test: #p < 0.05, ##p < 0.01.

Tables

  • Figures
    • View popup
    Table 1:

    Paired Student’s t test

    DataTestp
    a Figure 2AForce (g)No light vs 0.25 mW/mm2Paired Student’s t test0.0707
    • View popup
    Table 2:

    Repeated-measures two-way ANOVA

    DataSource of variation
    LightTimeInteractionMatching
    dfn, dfdFpdfn, dfdFpdfn, dfdFpdfn, dfdFp
    b Figure 2BForce (g)1, 109.2060.01262, 2049.6<0.00012, 204.7750.020210, 202.3710.0481
    c Figure 2CForce (g)1, 2312.630.00175, 11544.5<0.00015, 1157.556<0.000123, 1152.2980.0021
    d Figure 2DForce (g)1, 168.0390.01193, 487.7040.00033, 483.1940.031716, 482.3530.0115
    e Figure 2ELatency (s)1, 176.1920.02353, 516.7530.00063, 512.1110.110317, 511.4180.1672
    f Figure 3A, leftForce (g)1, 1211.970.00475, 6026.74<0.00015, 602.2850.057412, 602.5660.0082
    g Figure 3A, middleForce (g)1, 135.7690.0325, 6532.44<0.00015, 654.4240.001613, 651.0160.4471
    h Figure 3A, rightForce (g)1, 160.28230.60255, 8068.17<0.00015, 804.2930.001616, 801.7340.0567
    i Figure 3B, rightLatency (s)1, 120.57950.46128, 9663.15<0.00018, 962.2160.032712, 961.6340.0947
    j Figure 4, left50% threshold (g)1, 198.910.00765, 951.8260.11515, 951.8610.108519, 953.687<0.0001
    • dfn, df numerator; dfd, df denominator.

    • View popup
    Table 3:

    Multiple comparisons following repeated-measures two-way ANOVA

    DataTestp
    kFigure 2BAt 30 min: Ipsi-Light vs Ipsi-ControlSidak0.0018
    At 60 min: Ipsi-Light vs Ipsi-ControlSidak0.0424
    lFigure 2CAt 2 h: Ipsi-Light vs Ipsi-ControlSidak<0.0001
    At 4 h: Ipsi-Light vs Ipsi-ControlSidak0.0104
    At 6 h: Ipsi-Light vs Ipsi-ControlSidak0.0036
    mFigure 2DAt 1 h: Ipsi-Blue vs Ipsi-Blue + YellowSidak0.0034
    At 3 h: Ipsi-Blue vs Ipsi-Blue + YellowSidak0.0215
    n Figure 2EAt 1 h: Ipsi-Blue vs Ipsi-Blue + YellowSidak0.0106
    o Figure 3A, leftAt 2 h: Ipsi-Light vs Ipsi-ControlSidak0.0141
    At 4 h: Ipsi-Light vs Ipsi-ControlSidak0.0128
    p Figure 3A, middleAt 4 h: Ipsi-Light vs Ipsi-ControlSidak<0.0001
    q Figure 3A, rightAt 6 h: Ipsi-Light vs Ipsi-ControlSidak0.0007
    r Figure 3B, rightAt 24 (+1) h: Ipsi-Light vs Ipsi-ControlSidak0.0331
    s Figure 4, leftAt 1 h: SNI-Iso vs SNI-LightSidak0.0221
    At 2 h: SNI-Iso vs SNI-LightSidak0.0375
    • View popup
    Table 4:

    Repeated-measures one-way ANOVA

    DataTimeMatching
    dfn, dfdFpdfn, dfdFp
    tFigure 4, left50% threshold (g)3.54, 46.023.7830.012313, 653.6870.0002
    u Figure 4, middle50% threshold (g)2.142, 27.853.3040.048613, 523.2880.0011
    • dfn, df numerator; dfd, df denominator.

    • View popup
    Table 5.

    Multiple comparisons following repeated-measures one-way ANOVA

    DataTestp
    vFigure 4, leftSNI-Light: Pre vs 1 h PostDunnett’s0.0093
    SNI-Light: Pre vs 2 h PostDunnett’s0.0321
    SNI-Light: Pre vs 2.5 h PostDunnett’s0.0181
    SNI-Light: Pre vs 3 h PostDunnett’s0.0483
    w Figure 4, middleSNI-Light: Pre vs 1 h PostDunnett’s0.0437
Back to top

In this issue

eneuro: 3 (1)
eNeuro
Vol. 3, Issue 1
January/February 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain
Ihab Daou, Hélène Beaudry, Ariel R. Ase, Jeffrey S. Wieskopf, Alfredo Ribeiro-da-Silva, Jeffrey S. Mogil, Philippe Séguéla
eNeuro 25 February 2016, 3 (1) ENEURO.0140-15.2016; DOI: 10.1523/ENEURO.0140-15.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain
Ihab Daou, Hélène Beaudry, Ariel R. Ase, Jeffrey S. Wieskopf, Alfredo Ribeiro-da-Silva, Jeffrey S. Mogil, Philippe Séguéla
eNeuro 25 February 2016, 3 (1) ENEURO.0140-15.2016; DOI: 10.1523/ENEURO.0140-15.2016
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • allodynia
  • dorsal root ganglia
  • inflammation
  • neuropathy
  • optogenetics
  • spinal cord

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • Learning spatio-temporal properties of hippocampal place cells
  • A behavioral receptive field for ocular following in monkeys: Spatial summation and its spatial frequency tuning
  • Efferent Activity Controls Hair Cell Response to Mechanical Overstimulation
Show more New Research

Sensory and Motor Systems

  • Efferent Activity Controls Hair Cell Response to Mechanical Overstimulation
  • A behavioral receptive field for ocular following in monkeys: Spatial summation and its spatial frequency tuning
  • Optoception: Perception of Optogenetic Brain Perturbations
Show more Sensory and Motor Systems

Subjects

  • Sensory and Motor Systems

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.